FGEN - FibroGen, Inc

Day	1m	10m	60m	PreMarket	Market	AfterHours	Gap
11.09 -0.05 (-0.45%)	---	---	---	---	-0.05 (-0.45%)	---	---

FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia. The company operates in one reportable segment: the development and commercialization of novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates. Geographically, it operates in United States, Japan, Europe and Others.

Category: PHARMACEUTICAL PREPARATIONS

Market Period: AfterHours

Earnings & Ratios

Basic EPS:: -1.88
Diluted EPS:: -1.88
Basic P/E:: -5.8723
Diluted P/E:: -5.8723
RSI(14) 1m:: 25.0
VWAP:: 11.05
RVol:: 0.8461

Events

Period	Kind	Movement	Occurred At
1m	Price increase 1m	11.17 +0.12 (+1.09%)	Oct 15 15:33
1m	Price increase 1m	10.99 +0.14 (+1.28%)	Oct 15 14:55
1m	Price increase 1m	11.0 +0.18 (+1.62%)	Oct 15 14:48
1m	Price increase 1m	11.06 +0.13 (+1.14%)	Oct 15 11:48